Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ATNF
ATNF logo

ATNF Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
1.43M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
1.72M
EV/OCF(TTM)
--
P/S(TTM)
--
180 Life Sciences Corp. is a biotechnology company, which focuses on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Its programs include Anti-TNF (Clinical), Synthetic Cannabinoid Analogs (SCAs), and a7nAChR (Preclinical). The Company also operates a back-end technology platform to operate an online blockchain casino.
Show More

Events Timeline

(ET)
2025-08-18
13:50:08
ETHZilla unveils new brand and starts trading with a new ticker symbol.
select
2025-08-14 (ET)
2025-08-14
11:05:24
180 Life Sciences files to sell $500M of common stock
select
2025-08-12 (ET)
2025-08-12
11:14:44
180 Life Sciences announces total holdings of 82,186 ETH
select
2025-07-29 (ET)
2025-07-29
09:29:40
180 Life Sciences announces upsized $425M PIPE offering
select
2025-07-01 (ET)
2025-07-01
07:49:36
180 Life Sciences announces grants of two patents
select
2025-05-01 (ET)
2025-05-01
09:37:55
180 Life Sciences announces notice of allowance for U.S. patent
select
2025-04-30 (ET)
2025-04-30
08:55:21
180 Life Sciences to repurchase 1.32M shares from Elray for $1M
select
2025-04-30
08:44:24
180 Life Sciences enters settlement, mutual release agreement with Elray, Luxor
select
2024-12-27 (ET)
2024-12-27
08:07:19
180 Life Sciences prices $2.9M registered direct offering at $2.41 per share
select
2024-12-12 (ET)
2024-12-12
07:19:47
180 Life Sciences regains compliance with Nasdaq listing rule
select

News

Benzinga
4.5
2025-09-02Benzinga
EXCLUSIVE: Top 20 Most-Searched Stocks on Benzinga Pro for August – How Do Opendoor, Palantir, BitMine Immersion, and Apple Rank?
  • Most Searched Stocks: In August 2025, the most searched stocks on Benzinga Pro included SPDR S&P 500 ETF Trust (SPY), Palantir Technologies (PLTR), and Tesla Inc (TSLA), with notable movements in rankings, particularly Palantir rising to second place after dropping out of the top 20 in July.

  • Market Performance Insights: The article highlights significant year-to-date returns for stocks like BitMine Immersion Technologies (+523.1%) and Palantir (+108.4%), while others like BioXcel Therapeutics (-35.4%) and Tesla (-12.0%) faced declines, reflecting varied investor interest and market dynamics.

Benzinga
9.5
2025-08-15Benzinga
Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
  • KULR Technology Group Performance: KULR Technology Group, Inc. shares surged 19.3% in pre-market trading after reporting second-quarter revenue of $3.97 million and earnings of 22 cents per share, both exceeding estimates.

  • Market Movements: Several stocks experienced significant pre-market trading changes, with Perfect Moment Ltd rising 151% and Origin Materials, Inc. dropping 36.8% following their respective quarterly results.

Benzinga
4.5
2025-08-15Benzinga
Stock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus
  • Market Fluctuations: U.S. stock futures showed mixed movements following a hot Producer Price Index report, raising concerns about potential interest rate cuts by the Federal Reserve, while major indices like the Dow Jones and S&P 500 experienced slight changes in their values.

  • Corporate Developments: President Trump called for Intel CEO Lip-Bu Tan's resignation over alleged ties to China, while notable stock movements included UnitedHealth Group soaring after investments from prominent investors, and Deere & Co. shares falling due to lowered income outlook.

Benzinga
7.0
2025-08-15Benzinga
Applied Materials Issues Weak Outlook, Joins Globant, Sandisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
  • Market Overview: U.S. stock futures showed mixed results, with Dow futures up by 300 points, while Applied Materials, Inc. shares fell 14.7% in pre-market trading after issuing weak fourth-quarter guidance despite beating third-quarter revenue and earnings estimates.

  • Other Stocks Performance: Several other stocks, including Gambling.com Group Limited and Globant S.A., also experienced significant declines in pre-market trading following disappointing earnings reports or guidance.

Benzinga
2.0
2025-08-15Benzinga
180 Life Sciences Stock Slides After-Hours As Ethereum's Decline Triggers Massive Sell-Off
  • Stock Performance: 180 Life Sciences Corp. (ATNF) shares fell by 28% during regular trading, influenced by a decline in Ethereum's value, which the company heavily invests in, holding over $381 million worth of ETH.

  • Company Developments: The firm recently completed a $156 million private offering to acquire more ETH and plans to rebrand as ETHZilla Corporation, attracting significant investor interest, including billionaire Peter Thiel.

Benzinga
2.0
2025-08-14Benzinga
Deere, Coherent, North American Construction Group And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
  • U.S. Stock Market Overview: U.S. stock futures are slightly lower, with Dow futures down about 0.1%. Several companies, including Deere & Company and Ibotta, reported disappointing earnings, leading to significant drops in their stock prices during pre-market trading.

  • Notable Stock Movements: Deere shares fell 6% after a mixed earnings report; Ibotta's stock plummeted 32.4% due to revenue misses; other companies like Coherent Corp and North American Construction Group also saw substantial declines following poor financial results.

Valuation Metrics

The current forward P/E ratio for 180 Life Sciences Corp (ATNF.O) is -0.01, compared to its 5-year average forward P/E of -21.18. For a more detailed relative valuation and DCF analysis to assess 180 Life Sciences Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-21.18
Current PE
-0.01
Overvalued PE
45.07
Undervalued PE
-87.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.85
Current PS
0.19
Overvalued PS
15.53
Undervalued PS
-7.83

Financials

AI Analysis
Annual
Quarterly

Whales Holding ATNF

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is 180 Life Sciences Corp (ATNF) stock price today?

The current price of ATNF is 0 USD — it has increased 0

What is 180 Life Sciences Corp (ATNF)'s business?

180 Life Sciences Corp. is a biotechnology company, which focuses on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Its programs include Anti-TNF (Clinical), Synthetic Cannabinoid Analogs (SCAs), and a7nAChR (Preclinical). The Company also operates a back-end technology platform to operate an online blockchain casino.

What is the price predicton of ATNF Stock?

Wall Street analysts forecast ATNF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATNF is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is 180 Life Sciences Corp (ATNF)'s revenue for the last quarter?

180 Life Sciences Corp revenue for the last quarter amounts to -2.37M USD, increased 13.41

What is 180 Life Sciences Corp (ATNF)'s earnings per share (EPS) for the last quarter?

180 Life Sciences Corp. EPS for the last quarter amounts to USD, decreased

How many employees does 180 Life Sciences Corp (ATNF). have?

180 Life Sciences Corp (ATNF) has 4 emplpoyees as of April 01 2026.

What is 180 Life Sciences Corp (ATNF) market cap?

Today ATNF has the market capitalization of 1.43M USD.